pubmed-article:10861450 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0003691 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0475264 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10861450 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10861450 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10861450 | pubmed:dateCreated | 2000-7-13 | lld:pubmed |
pubmed-article:10861450 | pubmed:abstractText | The involvement of 12-lipoxygenase (12-LOX) expression and function in tumor metastasis has been demonstrated in several murine tumor cell lines. In addition, 12-LOX expression was detected in human prostatic tumors and correlated to the clinical stage of disease. Here we provide data that human prostate cancer cell lines express the platelet-type isoform of 12-LOX at both the mRNA and protein levels, and immunohistochemistry revealed 12-LOX expression in human prostate tumors. The enzyme was localized to the plasma membrane, cytoplasmic organelles and nucleus in non-metastatic cells (PC-3 nm) and to the cytoskeleton and nucleus in metastatic cells (DU-145). After orthotopic/intraprostatic injection of tumor cells into SCID mice, the metastatic prostate carcinoma cells (DU-145) expressed 12-LOX at a significantly higher level compared with the non-metastatic counterparts, PC-3nm. The functional involvement of 12-LOX in the metastatic process was demonstrated when DU-145 cells were pretreated in vitro with the 12-LOX inhibitors N-benzyl-N-hydroxy-5-phenylpentamide (BHPP) or baicalein, the use of which significantly inhibited lung colonization. These data suggest a potential involvement of 12-LOX in the progression of human prostate cancer. | lld:pubmed |
pubmed-article:10861450 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:language | eng | lld:pubmed |
pubmed-article:10861450 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10861450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10861450 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10861450 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10861450 | pubmed:issn | 0020-7136 | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:LORR | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:HagmannWW | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:HonnK VKV | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:OKAKK | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:TimárJJ | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:GrignonDD | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:DölzHH | lld:pubmed |
pubmed-article:10861450 | pubmed:author | pubmed-author:RásóEE | lld:pubmed |
pubmed-article:10861450 | pubmed:copyrightInfo | Copyright 2000 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:10861450 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10861450 | pubmed:day | 1 | lld:pubmed |
pubmed-article:10861450 | pubmed:volume | 87 | lld:pubmed |
pubmed-article:10861450 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10861450 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10861450 | pubmed:pagination | 37-43 | lld:pubmed |
pubmed-article:10861450 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:meshHeading | pubmed-meshheading:10861450... | lld:pubmed |
pubmed-article:10861450 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10861450 | pubmed:articleTitle | Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. | lld:pubmed |
pubmed-article:10861450 | pubmed:affiliation | Department of Tumor Progression, National Institute of Oncology, Budapest, Hungary. jtimar@oncol.hu | lld:pubmed |
pubmed-article:10861450 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10861450 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:10861450 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861450 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861450 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861450 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861450 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861450 | lld:pubmed |